Tumor Suppressor Loss in Pituitary Tumors
- 1 July 2001
- journal article
- review article
- Published by Wiley in Brain Pathology
- Vol. 11 (3) , 342-355
Abstract
The current model of human neoplasia invokes a number of potential genomic alterations that impact cellular phenotype and proliferative rates. In the majority of human tumor models, the transformation from normal cells to neoplastic lesion is a multistep process. This review offers a specific overview of the involvement of tumor suppressor genes (TSGs) in the pathogenesis of human pituitary adenomas. TSG genetic lesions, such as BRCA1 in breast cancer and p53 in Li‐Fraumeni Syndrome, have been identified in both sporadic and heritable human endocrine tumors. Familial neoplastic syndromes like multiple endocrine neoplasia type 1 (MEN1) that include pituitary tumor formation as part of a broad clinical spectrum of disease represent a unique opportunity to investigate the general mechanisms of tumorigenesis, and well as genes responsible for sporadic endocrine tumors. Similarly, homologous recombination knockout mice with selectively ablated candidate TSGs have also shed light on the molecular mechanisms of pituitary cell proliferation and tumor suppression. However, despite insights into pituitary tumorigenesis generated by heritable neoplasia syndromes and mouse knockout of critical TSGs that display a pituitary tumor phenotype, the molecular pathogenesis of human pituitary adenomas remains largely an enigma. Thus, the role of TSGs, if any, in sporadic pituitary adenoma formation has yet to be determined, despite our greater understanding of the molecular mechanisms underlying pituitary cell function and phenotype.Keywords
This publication has 41 references indexed in Scilit:
- Carney Complex--Clarity and ComplexityThe Journal of Clinical Endocrinology & Metabolism, 2000
- p16 (INK4a, MTS‐1) gene polymorphism and methylation status in human pituitary tumoursClinical Endocrinology, 1999
- Hypermethylation of thep16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomasGenes, Chromosomes and Cancer, 1999
- Loss of Heterozygosity on Chromosome 11q13 in Two Families with Acromegaly/Gigantism Is Independent of Mutations of the Multiple Endocrine Neoplasia Type I GeneThe Journal of Clinical Endocrinology & Metabolism, 1999
- Analysis of Loss of Heterozygosity on Chromosome 11 and Infrequent Inactivation of the MEN1 Gene in Sporadic Pituitary AdenomasThe Journal of Clinical Endocrinology & Metabolism, 1998
- Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumoursOncogene, 1998
- Frequent inactivation of thep16 gene in human pituitary tumors by gene methylationMolecular Carcinogenesis, 1997
- Inactivation of the Tumor Suppressor Gene on 11q13 in Brothers with Familial Acrogigantism without Multiple Endocrine Neoplasia Type 1The Journal of Clinical Endocrinology & Metabolism, 1997
- Effects of an Rb mutation in the mouseNature, 1992
- Elevated p53 RNA expression correlates with incomplete osteogenic differentiation of radiation‐induced murine osteosarcomasInternational Journal of Cancer, 1992